111 related articles for article (PubMed ID: 11425459)
1. Amplification of ERBB2, RARA, and TOP2A genes in a myelodysplastic syndrome transforming to acute myeloid leukemia.
Martín-Subero JI; Harder L; Gesk S; Schoch R; Novo FJ; Grote W; Calasanz MJ; Schlegelberger B; Siebert R
Cancer Genet Cytogenet; 2001 Jun; 127(2):174-6. PubMed ID: 11425459
[TBL] [Abstract][Full Text] [Related]
2. Aberrations of ERBB2 and TOP2A genes in breast cancer.
Nielsen KV; Müller S; Møller S; Schønau A; Balslev E; Knoop AS; Ejlertsen B
Mol Oncol; 2010 Apr; 4(2):161-8. PubMed ID: 19945923
[TBL] [Abstract][Full Text] [Related]
3. Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.
Järvinen TA; Tanner M; Bärlund M; Borg A; Isola J
Genes Chromosomes Cancer; 1999 Oct; 26(2):142-50. PubMed ID: 10469452
[TBL] [Abstract][Full Text] [Related]
4. Allelic fusion of DNA topoisomerase II alpha and retinoic acid receptor alpha genes in adriamycin-resistant p388 murine leukemia revealed by fluorescence in situ hybridization.
Squire JA; McPherson JP; Beatty BG; Goldenberg GJ
Cytogenet Cell Genet; 1996; 75(2-3):164-6. PubMed ID: 9040785
[TBL] [Abstract][Full Text] [Related]
5. Acute myelomonocytic leukaemia and 48,XXY, +8 chromosome anomalies.
Ng JP; Challinor P; Strevens MJ
Clin Lab Haematol; 1992; 14(1):81-5. PubMed ID: 1600697
[No Abstract] [Full Text] [Related]
6. Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines.
Arriola E; Marchio C; Tan DS; Drury SC; Lambros MB; Natrajan R; Rodriguez-Pinilla SM; Mackay A; Tamber N; Fenwick K; Jones C; Dowsett M; Ashworth A; Reis-Filho JS
Lab Invest; 2008 May; 88(5):491-503. PubMed ID: 18332872
[TBL] [Abstract][Full Text] [Related]
7. Amplification of the RARA gene in acute myeloid leukemia: significant finding or coincidental observation?
Asleson AD; Morgan V; Smith S; Velagaleti GV
Cancer Genet Cytogenet; 2010 Oct; 202(1):33-7. PubMed ID: 20804918
[TBL] [Abstract][Full Text] [Related]
8. Translocation (13;17)(q14;q25) as a novel chromosomal abnormality in acute myeloid leukemia-M4.
Turhan N; Yürür-Kutlay N; Topcuoglu P; Sayki M; Yüksel M; Gürman G; Tükün A
Leuk Res; 2006 Jul; 30(7):903-5. PubMed ID: 16469377
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetics and fluorescence in-situ hybridization in detection of hematological malignancies.
Frenny VJ; Antonella Z; Luisa A; Shah AD; Sheth JJ; Rocchi M
Indian J Cancer; 2003; 40(4):135-9. PubMed ID: 14716109
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase II alpha gene copy loss has adverse prognostic significance in ERBB2-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts.
Usha L; Tabesh B; Morrison LE; Rao RD; Jacobson K; Zhu A; Basu S; Coon JS
J Hematol Oncol; 2008 Aug; 1():12. PubMed ID: 18702822
[TBL] [Abstract][Full Text] [Related]
11. Gene copy mapping of the ERBB2/TOP2A region in breast cancer.
Jacobson KK; Morrison LE; Henderson BT; Blondin BA; Wilber KA; Legator MS; O'Hare A; Van Stedum SC; Proffitt JH; Seelig SA; Coon JS
Genes Chromosomes Cancer; 2004 May; 40(1):19-31. PubMed ID: 15034864
[TBL] [Abstract][Full Text] [Related]
12. Trisomy 4 and ring chromosome in a patient with acute myelomonocytic leukemia.
Vicari L; Sebastio L; Stanziola MC; Fasanaro A; Ferrara F
Haematologica; 1994; 79(1):83-5. PubMed ID: 15378955
[TBL] [Abstract][Full Text] [Related]
13. t(7;11) and trilineage myelodysplasia in acute myelomonocytic leukemia.
Inaba T; Shimazaki C; Yoneyama S; Hirai H; Kikuta T; Sumikuma T; Sudo Y; Yamagata N; Ashihara E; Goto H; Fujita N; Nakagawa M
Cancer Genet Cytogenet; 1996 Jan; 86(1):72-5. PubMed ID: 8616792
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of TOP2A gene amplification and chromosome 17 polysomy in early breast cancer.
Zaczek A; Markiewicz A; Supernat A; Bednarz-Knoll N; Brandt B; Seroczyńska B; Skokowski J; Szade J; Czapiewski P; Biernat W; Wełnicka-Jaśkiewicz M; Jassem J
Pathol Oncol Res; 2012 Oct; 18(4):885-94. PubMed ID: 22426810
[TBL] [Abstract][Full Text] [Related]
15. Rare t(1;11)(q23;p15) in therapy-related myelodysplastic syndrome evolving into acute myelomonocytic leukemia: a case report and review of the literature.
Zhang L; Alsabeh R; Mecucci C; La Starza R; Gorello P; Lee S; Lill M; Schreck R
Cancer Genet Cytogenet; 2007 Oct; 178(1):42-8. PubMed ID: 17889707
[TBL] [Abstract][Full Text] [Related]
16. TOP2A and HER-2 gene amplification in fine needle aspirates from breast carcinomas.
Bofin AM; Ytterhus B; Hagmar BM
Cytopathology; 2003 Dec; 14(6):314-9. PubMed ID: 14632728
[TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.
Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH
Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response.
Reinholz MM; Bruzek AK; Visscher DW; Lingle WL; Schroeder MJ; Perez EA; Jenkins RB
Lancet Oncol; 2009 Mar; 10(3):267-77. PubMed ID: 19261255
[TBL] [Abstract][Full Text] [Related]
19. A novel t(15;17) translocation in acute myeloid leukaemia not associated with PML/RARalpha rearrangement.
Cotter M; Enright H
Clin Lab Haematol; 2003 Aug; 25(4):255-7. PubMed ID: 12890166
[TBL] [Abstract][Full Text] [Related]
20. Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer.
Varga Z; Tubbs RR; Wang Z; Sun Y; Noske A; Kradolfer D; Bosshard G; Jochum W; Moch H; Öhlschlegel C
Breast Cancer Res Treat; 2012 Apr; 132(3):925-35. PubMed ID: 21698407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
